Mercy BioAnalytics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
47
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$59M
- Investors
-
24
Mercy BioAnalytics General Information
Description
Developer of a novel liquid biopsy assay platform designed to relieve suffering and save lives through the early detection of cancer. The company's platform interrogates tumor-derived extracellular vesicles, which are abundant in blood and carry information about their cell of origin, enabling patients to detect various types of cancer at the earliest stages.
Contact Information
Website
www.mercybio.comCorporate Office
- 880 Winter Street
- Suite 2003
- Waltham, MA 02451
- United States
Corporate Office
- 880 Winter Street
- Suite 2003
- Waltham, MA 02451
- United States
Mercy BioAnalytics Timeline
Mercy BioAnalytics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B) | 28-Aug-2025 | $59M | Completed | Generating Revenue | ||
| 4. Later Stage VC (Series A) | 08-Mar-2023 | Completed | Generating Revenue | |||
| 3. Seed Round | 29-Jan-2021 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Mercy BioAnalytics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Mercy BioAnalytics Comparisons
Industry
Financing
Details
Mercy BioAnalytics Competitors (1)
One of Mercy BioAnalytics’s competitors is Freenome, a Formerly VC-backed company based in Brisbane, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Freenome | Formerly VC-backed | Brisbane, CA |
Mercy BioAnalytics Patents
Mercy BioAnalytics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026226814-A1 | Methods of biomarker detection on particles | Pending | 24-Apr-2025 | ||
| US-20260338785-A1 | Multiplex method for multiple biomarker detection on particles | Pending | 24-Apr-2025 | ||
| WO-2026226813-A1 | Multiplex method for multiple biomarker detection on particles | Pending | 24-Apr-2025 | ||
| WO-2026226815-A1 | Multiplex method for multiple biomarker detection on particles | Pending | 24-Apr-2025 | ||
| EP-4837131-A1 | Pooling samples for screening diagnostics | Pending | 03-Jan-2025 |
Mercy BioAnalytics Signals
Mercy BioAnalytics Investors (24)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Hologic | PE-Backed Company | Minority | ||
| Mindshift Capital | Venture Capital | Minority | ||
| Perceptive Advisors | Venture Capital | Minority | ||
| Portfolia | Venture Capital | Minority | ||
| Xontogeny | Accelerator/Incubator | Minority |
Mercy BioAnalytics FAQs
-
When was Mercy BioAnalytics founded?
Mercy BioAnalytics was founded in 2018.
-
Where is Mercy BioAnalytics headquartered?
Mercy BioAnalytics is headquartered in Waltham, MA.
-
What is the size of Mercy BioAnalytics?
Mercy BioAnalytics has 47 total employees.
-
What industry is Mercy BioAnalytics in?
Mercy BioAnalytics’s primary industry is Decision/Risk Analysis.
-
Is Mercy BioAnalytics a private or public company?
Mercy BioAnalytics is a Private company.
-
What is Mercy BioAnalytics’s current revenue?
The current revenue for Mercy BioAnalytics is .
-
How much funding has Mercy BioAnalytics raised over time?
Mercy BioAnalytics has raised $127M.
-
Who are Mercy BioAnalytics’s investors?
Hologic, Mindshift Capital, Perceptive Advisors, Portfolia, and Xontogeny are 5 of 24 investors who have invested in Mercy BioAnalytics.
-
Who are Mercy BioAnalytics’s competitors?
Freenome is a competitor of Mercy BioAnalytics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process